Amelia Tope

Amelia Tope is the former Associate Editor of Ophthalmology Times Europe. She may be reached by Tel: +44 (0)1244 393 153 or E-mail: atope@advanstar.com

With the increasing number of multifocal and accommodative intraocular lens (IOL) implantations being carried out, cataract surgery is fast becoming another form of refractive surgery.

The use of ophthalmic solutions tends to increase with age; however, as use of these solutions, both therapeutic and diagnostic, rises, so too does a patient's risk of infections.

Children who are blind and disabled are often hidden in the society because of stigma, prejudice and negative attitudes of the able-bodied members of the family and community

blah

blah

A look back at what has happened in the field of glaucoma in 2007 and what we can look forward to in 2008.

blah

blah

The field of age-related macular degeneration (AMD) research continues to experience exciting and fascinating times, with the recent launches of new therapeutics and several others on the horizon giving hope to more patients than ever before. Coupled with advances in imaging and diagnostic technology, retina specialists now face AMD with fresh optimism — treatments and technologies are available that will help them to delay or maybe even halt disease progression in their patients.